跳至主要内容
临床试验/IRCT201110233930N15
IRCT201110233930N15已完成3 期

Aripiprazole versus risperidone for treatment of autism

Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 18 years(—)
性别
All

入选标准

  • Inclusion Criteria: DSM-IV diagnosis of autism spectrum disorders; both genders; being able to eat medication; providing written informed consent.

排除标准

  • unstable medical condition; evidence of active liver disease; unstable hypertension or cardiac disease; unstable asthma; and kidney disease as determined by the investigator; subjects who are allergic to the medications; initiation of new behavioral therapy.

研究者

发起方
Vice chancellor for research, Shiraz University of Medical Sciences

相似试验